BioAffinity Technologies Inc [NASDAQ: BIAF] stock went on a downward path that fall over -6.55% on Wednesday, amounting to a one-week price decrease of less than -14.68%.
Over the last 12 months, BIAF stock dropped by -87.44%. The one-year BioAffinity Technologies Inc stock forecast points to a potential upside of 95.83. The average equity rating for BIAF stock is currently 1.00, trading closer to a bullish pattern in the stock market.
The market cap for the stock reached $7.15 million, with 28.46 million shares outstanding and 20.25 million shares in the current float. Compared to the average trading volume of 12.25M shares, BIAF stock reached a trading volume of 9157815 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Guru’s Opinion on BioAffinity Technologies Inc [BIAF]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for BIAF shares is $6.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on BIAF stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
The Average True Range (ATR) for BioAffinity Technologies Inc is set at 0.05, with the Price to Sales ratio for BIAF stock in the period of the last 12 months amounting to 0.81. The Price to Book ratio for the last quarter was 3.18, with the Price to Cash per share for the same quarter was set at 0.02.
BIAF Stock Performance Analysis:
BioAffinity Technologies Inc [BIAF] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -14.68. With this latest performance, BIAF shares gained by 11.58% in over the last four-week period, additionally sinking by -73.00% over the last 6 months – not to mention a drop of -87.44% in the past year of trading.
Insight into BioAffinity Technologies Inc Fundamentals:
Operating Margin for any stock indicates how profitable investing would be, and BioAffinity Technologies Inc [BIAF] shares currently have an operating margin of -109.38% and a Gross Margin at 27.48%. BioAffinity Technologies Inc’s Net Margin is presently recorded at -110.55%.
Return on Equity for this stock declined to -143.25%, with Return on Assets sitting at -143.25%.
BioAffinity Technologies Inc [BIAF] Institutonal Ownership Details
There are presently around $1.80%, or 2.38%% of BIAF stock, in the hands of institutional investors. The top three institutional holders of BIAF stocks are: VANGUARD GROUP INC with ownership of 0.17 million shares, which is approximately 1.5101%. GEODE CAPITAL MANAGEMENT, LLC, holding 69600.0 shares of the stock with an approximate value of $$0.15 million in BIAF stocks shares; and GEODE CAPITAL MANAGEMENT, LLC, currently with $$60232.0 in BIAF stock with ownership which is approximately 0.2448%.
